Citations

Showing 10 of 108083 citations.

Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO
Weinshenker, Brian G. , Tobin, W. Oliver , Weinshenker, Brian G

Mayo Clinic

Multiple Sclerosis Journal | July 27, 2017 | Volume: 23 | Issue: 9 | Pages: 1190-1192

10.1177/1352458517702556 | PMID 28673112 Get It

Update in perioperative medicine: practice changing evidence published in 2016
Regan, Dennis W., Kashiwagi, Deanne T. , Dougan, Brian M. , Sundsted, Karna K. , Mauck, Karen F. , Kashiwagi, Deanne, Dougan, Brian, Sundsted, Karna, Mauck, Karen

Mayo Clinic

Hospital Practice | July 27, 2017 | Volume: 45 | Issue: 4 | Pages: 158-164

10.1080/21548331.2017.1359060 | PMID 28749248 Get It

Temporal and spatial heterogeneity of programmed cell death 1-Ligand 1 expression in malignant mesothelioma
Terra, Simone , Mansfield, Aaron S. , Peikert, Tobias, Roden, Anja C. , Terra, Simone B S P, Dong, Haidong , Mansfield, Aaron S , Terra, Simone B S P

Mayo Clinic

OncoImmunology | July 27, 2017 | Volume: 6 | Issue: 11 | Pages: e1356146

10.1080/2162402x.2017.1356146 | PMID 29147606 Get It

Front Cover: The Thermodynamic Effects of Ligand Structure on the Molecular Recognition of Mononuclear Ruthenium Polypyridyl Complexes with B‐DNA (Eur. J. Inorg. Chem. 30/2017)
Mikek, Clinton G. , DuPont, Jesse I. , Machha, Venkata R. , White, Jake C., Martin, Logan R. , Alatrash, Nagham , MacDonnell, Frederick M. , Lewis, Edwin A.

Mayo Clinic

European Journal of Inorganic Chemistry | July 27, 2017 | Volume: 2017 | Issue: 30 | Pages: 3587-3587

10.1002/ejic.201700777 Get It

The Thermodynamic Effects of Ligand Structure on the Molecular Recognition of Mononuclear Ruthenium Polypyridyl Complexes with B‐DNA
Mikek, Clinton G. , DuPont, Jesse I. , Machha, Venkata R. , White, Jake C., Martin, Logan R. , Alatrash, Nagham , MacDonnell, Frederick M. , Lewis, Edwin A.

Mayo Clinic

European Journal of Inorganic Chemistry | July 27, 2017 | Volume: 2017 | Issue: 30 | Pages: 3588-3588

10.1002/ejic.201700778 Get It

AbstractInvited for the cover of this issue is the group of Edwin Lewis, Mississippi State University, in collaboration with Frederick MacDonnell, University of Texas at Arlington, USA. The cover image shows Ru(phen)2(tatpp)]2+ binding to DNA.
Proliferation and Differentiation Characteristics of Normal Human Squamous Mucosal Cells of the Upper Aerodigestive Tract
Kasperbauer, Jan L. , Neel, H. Bryan, Scott, Robert E.

Mayo Clinic

Annals of Otology, Rhinology & Laryngology | July 27, 2017 | Volume: 99 | Issue: 1 | Pages: 29-37

10.1177/000348949009900105 | PMID 2403769 Get It

Normal human squamous mucosal cells of the soft palate, buccal surface, epiglottis, hypopharynx, floor of the mouth, and tongue were cultured in vitro in serum-free medium. In medium MCDB 153 containing epidermal growth factor, insulin, bovine pituitary extract, and 0.1 or 2.0 mmol/L Ca ** , squamous mucosal cells double every 24 hours. These cells then can be induced to arrest their proliferation reversibly by treatment with transforming growth factor-β or ethionine, and they can irreversibly growth-arrest during senescence or when cultured in growth factor–deficient medium containing 2 mmol/L Ca ** . The latter medium also induces differentiation, as does culture of cells in serum-containing medium. Serum-containing medium furthermore promotes extensive cell stratification and the formation of multilayered squamous mucosal tissue specimens that can be removed intact by Dispase treatment. These specimens represent potential autogenous mucosal grafts that can be used in patients who require reconstructive surgery of the oral cavity and oropharynx. Normal human squamous mucosal cells therefore closely resemble keratinocytes derived from the epidermis in the mechanisms that regulate proliferation and differentiation. This model cell system should facilitate future studies on upper aerodigestive tract squamous mucosal cell physiology and pathophysiology.
Re: Placebo responses in device studies
Goadsby, Peter J. , Dodick, David W. , Lipton, Richard B.

Mayo Clinic

Cephalalgia | July 27, 2017 | Volume: 38 | Issue: 5 | Pages: 1007-1008

10.1177/0333102417722498 | PMID 28747062 Get It

Simple Therapy for Simple Diseases, Here as well as Abroad
Stickler, Gunnar B.

Mayo Clinic

Clinical Pediatrics | July 27, 2017 | Volume: 14 | Issue: 12 | Pages: 1157-1160

10.1177/000992287501401210 | PMID 127684 Get It

Endovascular Repair of a Thoracoabdominal Aortic Aneurysm With a Patient-Specific Fenestrated-Branched Stent-Graft
Mendes, Bernardo C. , Greiten, Lawrence E. , Oderich, Gustavo S.

Mayo Clinic

Journal of Endovascular Therapy | July 27, 2017 | Volume: 24 | Issue: 5 | Pages: 665-669

10.1177/1526602817722153 | PMID 28747079 Get It

Purpose: To describe the technical aspects of a thoracoabdominal aortic aneurysm (TAAA) repair using a patient-specific fenestrated-branched stent-graft. Technique: The technique is demonstrated in a 69-year-old man with a 6.2-cm asymptomatic type III TAAA. A patient-specific fenestrated-branched stent-graft was designed with 2 down-going directional branches for the celiac and superior mesenteric arteries and 2 reinforced fenestrations for the renal arteries. The procedure was performed under general anesthesia and included sequential stenting of the celiac, superior mesenteric, and bilateral renal arteries. The patient was discharged from the hospital on postoperative day 5 with no complications. Follow-up computed tomography angiography demonstrated exclusion of the aneurysm and patent target vessels at 12-month follow-up. Conclusion: This article and illustrated video highlight the steps for procedure planning and implantation of fenestrated and branched endografts. As these techniques continue to evolve, outcomes are expected to be equivalent or improved as compared to those of long-established open repair.